| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.35 | 6e-09 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | -0.22 | 1e-08 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.31 | 2e-08 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | -0.19 | 6e-07 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.18 | 1e-06 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | -0.18 | 1e-06 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.18 | 1e-06 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.19 | 2e-06 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.17 | 2e-06 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.28 | 2e-06 |